Physician profile
Anna Edmiston
NPI 1386055762
$4,688.25
in general payments reported to CMS, 2019-2025
17 companies · $935 in 2025
The $935 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,480 · 2020: $400 · 2021: $128 · 2022: $172 · 2023: $326 · 2024: $247 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908 · Consulting Fee: $575 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.78 |
| Consulting Fee | $575.00 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $1,699.06 | 2019 | |
| Bausch & Lomb Americas INC. | $740.24 | 2023-2025 | Stellaris Elite, Envista Mx60 Iol, Ic-8 Apthera Iol |
| Carl Zeiss Meditec, INC. | $429.97 | 2020-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $415.30 | 2019-2020 | |
| Rxsight INC | $282.82 | 2021-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Alcon Vision LLC | $258.83 | 2020-2025 | Clareon, Wavelight Sightmap |
| Johnson & Johnson Surgical Vision, INC. | $217.89 | 2023-2025 | Tecnis Simplicity, Tecnis Iol |
| Shire North American Group INC | $203.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $128.97 | 2021-2022 | |
| Staar Surgical Company | $80.35 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $62.16 | 2022-2024 | |
| Ocular Therapeutix, INC. | $43.07 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $34.05 | 2024 | |
| Eyepoint US, INC. | $31.41 | 2019 | |
| Omeros Corporation | $25.93 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.38 | 2022 | |
| The Cameron-Ehlen Group, INC. | $12.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Edmiston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.